Suppr超能文献

用于肝细胞癌治疗的射频消融术的最新进展

Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

作者信息

Himoto Takashi, Kurokohchi Kazutaka, Watanabe Seishiro, Masaki Tsutomu

机构信息

Department of Integrated Medicine, Kagawa, Japan.

出版信息

Hepat Mon. 2012 Oct;12(10 HCC):e5945. doi: 10.5812/hepatmon.5945. Epub 2012 Oct 10.

Abstract

UNLABELLED

CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.

EVIDENCE ACQUISITION

At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.

RESULTS

New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.

CONCLUSIONS

This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.

摘要

未标注

背景:肝细胞癌(HCC)是世界上最常见的恶性疾病之一。由于不到20%的HCC患者可进行手术切除,因此已开发出各种类型的非手术治疗方法。

证据获取

目前,射频消融(RFA)因其与其他局部治疗相比具有更好的局部控制和总生存率,被公认为HCC患者的标准局部治疗方法。

结果

已开发出用于RFA的新设备以及RFA与其他手术的联合治疗方法,以提高抗肿瘤效果。

结论

本综述主要关注RFA在HCC治疗中的现状以及RFA治疗技术的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ddf/3496873/b604e96db7fe/hepatmon-12-10-5945-i001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验